Medicine Archives - Page 3 of 3

Phesi celebrates 100 million global patient data milestone

The company, a provider of patient-centric data analytics made the announcement today (February 6), that this unparalleled volume of data

Kinnov Therapeutics alcohol use disorder (AUD) drug progressing well

Historically, the recommended treatment has focused on abstinence and achieving complete sobriety. However, having observed this method’s lack of efficacy,

finding cancer trial patients like finding needle in haystack

The company recently announced its Omnichannel Network partnership with Massive Bio, a global leader in AI-enabled patient journey mapping platform, to

Lightship at SCOPE 2024 – and its people first approach to trials

Motivated by a commitment to underserved populations, he joined Lightship to prioritize access, choice, and equity in clinical trials, ensuring

Lokavant’s trial platform – a game-changer in the industry

He says Lokavant’s solution can provide valuable insights to help streamline your trial process and ensure its success. 1.Why do

AI trend to continue at SCOPE 2024

She has more than 15 years in the life science technology industry significant experience in the investigator grant administration domain

Repare Therapeutics receives $40 million Roche payment

It earned the milestone payment from Roche for developing and commercializing camonsertib (RP-3500 or RG6526), an oral small molecule drug

EDETEK platform delivers custom configurable workflows

EDETEK provides clinical technology solutions for the biopharmaceutical, medical devices and CRO companies. The new product forms part of the

Evaro secures $1.5 million to transform minor healthcare access

Evaro was founded in 2018 by Thuria Wenbar, an emergency doctor and software developer, and her husband, Oskar Wendowski, a

NeoPhore’s small molecule drugs pipeline gets additional £9.6M

Neophore Limited, a neoantigen immune-oncology company, is generating next-generation, immuno-oncology therapeutics to improve clinical outcomes for cancer patients made the

Stevanato bringing advanced biopharmaceutical products to market

The company announced that the two new solutions for efficient small batch pharmaceutical manufacturing – the EZ-fill Kit and the

GSK drug for enlarged spleen given UK marketing authorisation by MRHA

The drug is for the treatment of disease-related splenomegaly (enlarged spleen) or symptoms in adult patients with moderate to severe

Stevanato bringing advanced biopharmaceutical products to market

The company announced that the two new solutions for efficient small batch pharmaceutical manufacturing – the EZ-fill Kit and the

Good news for Hong Kong as colorectal cancer treatment approved

The announcement was made today (January 30) that there was marketing approval by the Pharmacy and Poisons Board of Honk

IQVIA: Healthcare data regional compliance complexity requires AI, ML and NLP automation

Always the buzz theme at pharma conferences, the subject of artificial intelligence (AI) continues to crop up more and more

Pistoia Alliance flagship project IDMP-O published

The global not-for-profit alliance advocates for ‘greater collaboration in life sciences research and development and now plans to support the

Curavit at SCOPE 2024 – on seeing green shoots in the industry

The company uses technologies in digital health, cloud computing, and data science to recruit, engage, and monitor diverse patient populations

SCOPE the place to connect and have meaningful chats

The company provides integrated solutions that safeguard trial participants, empower clinical sites, ensure compliance, and optimize research performance and is

Medable’s hope – driving down the 12-year drug development lifecycle

The company provides an end-to-end, global cloud platform with a flexible suite of tools that allows sponsors, patients, providers &

SCOPE 2024 – the top space for collaboration across clinical development

The company’s goal is to help life sciences organizations around the world accelerate clinical development initiatives with expert biometrics services

SCOPE 2024 – driving innovation in clinical trials

At the zenith of innovation, OM1 crafts solutions that harness the potential of real-world data and artificial intelligence with solutions

Breye Therapeutics ApS developing oral ophthalmology drugs

Breye Therapeutics ApS announced today (January 25) that the first patient has been dosed in a phase 1b/2a clinical trial

Partnership to enhance efficiency of development for cancer medicine

The two companies aim to develop the next wave of imaging-based diagnostics for precision medicine. Merck is a leading science

AI trend to continue at SCOPE 2024

She has more than 15 years in the life science technology industry significant experience in the investigator grant administration domain

Veeva at SCOPE – primary focus will be driving innovation

We put some questions to him in advance of the summit. What are the current top priorities for the clinical

Colleen Acosta – addressing the unmet needs in women’s health

Could you give us an overview of your work? We have a world class team of leaders in the fields

Gerresheimer medical device manufacturer $88 milliion expansion in US

The expansion will create more than 200 new jobs adding to the 260 it already supports there. The German-based company

Saama platform users now get instant responses to data queries

The company uses AI and advanced analytics to automate key clinical development processes in a bid to accelerate time to

Sano Genetics raises $11.4 million for precision medicine

The raise was led by Plural with participation from existing investors including MMC Ventures, Episode 1, and Seedcamp. The announcement

Clinical Trial Media launches online portal for studies and trials

The company works with pharmaceutical companies through all stages of clinical research made the announcement earlier this month (January 2024).

Luka Yancopoulos, CEO of Grapevine, on data management and supply chains

Luka Yancopoulos is CEO of Grapevine and explains the importance, and challenges, of standardizing data from different sources in order to

SGD Pharma’s goal to become market leader in glass packaging

CEO Olivier Rousseau says that SGD Pharma intends to significantly grow in 2024, with a sustained and consistent approach to

the importance of federal learning for clinical research

He developed a paper on clinical development to proactively address industry issues earlier this month and OSP put some questions

SmartLabs’ $48 million funding to accelerate scientific development

The company provides flexible laboratory infrastructure and resourcing solutions and welcomed the participation to the funding round from ArrowMark Partners,

Nitisinone brought to rare disease patients thanks to partnership

The partnership, announced today (January 18) will make NITYR (nitisinone) tablets available for eligible patients in the UK with Hereditary

GSK’s £200 million investment in the UK and $1.1 billion acquisition

The company formerly known as Glaxosmithkline will put the money towards its sites there until 2025 including constructing new facilities

the need for clearly defined regulatory approval

A tour of a mock home with all the technology in place was certainly eye-opening, so we were keen to

Investment of €10 million for drug delivery company DelSiTech

The financing was co-led by new investors DRW Venture Capital LLC, headquartered in Chicago, and Tolmar International Ltd., based in

KBI Biopharma and Argonaut Manufacturing Services form strategic alliance

The companies say the arrangement provides the seamless manufacturing by combining KBI’s leading drug development and biologics manufacturing services with

Cormica Bradford equipment expansion supporting key client programs

The company says it is known for its ‘unwavering commitment to enhancing patient lives through comprehensive testing services’ and that

Nutriband Inc. signs fentanyl agreement with Kindeva Drug Delivery

Nutriband Inc., a company that develops transdermal pharmaceutical products has signed a commercial development and clinical supply agreement with its

Medable hopes new technology will cut trial build time by half

The company that provides technology for modern clinical trials says early application of the technology in electronic clinical outcomes assessment

Gen Li, president and founder of Phesi on data management

Here’s a summary of our question and answer session. How has the role of data management in clinical development changed?

Picodya’s new technology enables real-time monitoring of human immune status

The company is the creator of the first hybrid in vitro diagnostics (IVD) solution for multiplexed point-of-care testing (xPOCT) and

MilliporeSigma and ACD/Labs in collaboration for ChemTwins platform

MilliporeSigma’s first release version of its digital reference material (dRM) ChemisTwin provides scientists in quality control labs with an automated

Fortrea, Advarra and Veeva form partnership to reduce trial burdens

The partnership aims to deliver an integrated patient- and site-centric solution provoding a smooth and effective clinical trial experience. Fortrea

Luka Yancopoulos, CEO of Grapevine, on data management and supply chains

Luka Yancopoulos is CEO of Grapevine and explains the importance, and challenges, of standardizing data from different sources in order to

WNS on the trials and tribulations of data management

The company says that if business partners are able to harness health date with strong partnerships with the healthcare industry,

Hutchmed’s hope for adults with primary immune thrombocytopenia

The company has announced new drug application (NDA) acceptance in China for its small molecule drug, sovleplenib, and it has

Nadège Pelletier from childhood microscope to CSO

OSP: Could you give us an overview of your work? As the CSO, I lead Barinthus Bio’s scientific and technical

Evotec joins forces with the Crohn’s & Colitis Foundation

The foundation is the leading non-profit organization focused on both research and patient support for inflammatory bowel disease (IBD), which

New technology could ‘meaningfully impact’ brain trauma

According to the company, its central nervous system (CNS) CAPTON platform improves distribution and proportionate drug activity based on pathology

Newron’s evenamide brings good news for patients with CNS diseases

The company, which focuses on the development of therapies for patients with diseases of the central nervous system (CNS) said

ACG joins coveted list of WEF’s Global Lighthouse Network

The company that says it is the largest of its kind, is celebrating the inclusion of its capsule manufacturing facility

Thermo Fisher’s hope to improve outcomes for ARDS patients

The PPD clinical research business of Thermo Fisher Scientific Inc., a world leader in serving science, has been selected by

Thermo Fisher’s hope to improve outcomes for ARDS patients

The PPD clinical research business of Thermo Fisher Scientific Inc., a world leader in serving science, has been selected by

Ketamine myths dispelled by clinic following Matthew Perry’s death

Mental health treatment center, the Ketamine Clinics Los Angeles (KCLA) said the storm surrounding the recently announced cause of death

Bristol Myers Squibb buys Karuna Therapeutics for $14 billion

The board of directors at Karuna, a founded entity of PureTech Health, and Bristol Myers Squibb unanimously approved the transaction

Ketamine myths dispelled by clinic following Matthew Perry’s death

Mental health treatment center, the Ketamine Clinics Los Angeles (KCLA) said the storm surrounding the recently announced cause of death

Calliditas IgAN treatment, Tarpeyo, given full FDA approval

IgAN or primary immunoglobulin A neuropathy is an autoimmune disease that occurs when clumps of antibodies are deposited in your kidneys,

Merck launches SaaS platform with 60 billion possibilities

The Aiddison drug discovery software works through Synthia retrosynthesis software application programming interface (API) integration and Merck says it combines

CellCentric gives hope to last-line multiple myeloma patients

UK-based biotech, CellCentric which spun out of Cambridge University has yesterday (December 11) announced new clinical data for the drug

Neurological diseases focus of Pharmakure’s alliance with Malaysian university

The company will now work with the faculty of pharmacy at Universiti Teknologi MARA (UiTM) with the partnership focused on

HIV pathology data now reaching investigators within hours

Established in 1994 and funded by the National Institutes of Health and National Cancer Institution has opted to use Proscia’s

CEO at Vector Laboratories’ instant passion for science

She discovered a passion for science after her very first chemistry lesson and found the subject came easily to her.

Lindus Health and Thirty Madison’s pilot dermatology study

Treatments for various skin conditions, including atopic dermatitis (eczema), can be sought via the platform through asynchronous evidence-based consultation, patient-reported

Atropos Health and SEQESTER partner to speed up drug development

Atropos Health translates real-world clinical date into personalized real-world evidence and insights announced its partnership with SEQESTER today (December 14).

Deep Apple’s $52 million funding revolutionizing drug discovery

Deep Apple Therapeutics discovers the therapeutics for high-value targets through virtual screening of artificial intelligence (AI)-generated virtual libraries. With a

Mission Therapeutics moves kidney disease drug to phase 2 after FDA approval

Up to 160 adults with increased risk for acute kidney injury (AKI) following cardiac surgery are planned to be recruited

UK approves treatment for hot flushes during the menopause

“Hot flushes and night sweats caused by menopause are common, and can have a significant impact on a woman’s daily

New appointments in the pharma industry

Related tags People on the move Pharma industry Jobs Pharmaceutical industry BioPharma Reporter and Outsourcing Pharma presents its latest round-up

The key pharmaceutical trends from 2023 according to industry leaders

There has been no shortage of excitement over 2023 with a huge number of impactful stories. We have seen big

Five decentralized clinical trial organizations raising big VC cash

As the Covid-19 pandemic raged, lockdowns and strained healthcare systems forced many clinical trials to be delayed or to seek

Agno Pharma snaps up Particle Sciences to beef up drug product formulation

The acquisition has added Particle Sciences’ specialized drug product formulation technology to the CDMO’s toolkit in addition to the firm’s

FDA approves Arcutis’ skin foam for seborrheic dermatitis

The US Food and Drug Administration (FDA) has approved a topical foam developed by Arcutis Biotherapeutics and branded as Zoryve

‘Motherhood makes me a stronger, more compassionate employee’

We discussed what drew her to the field, her career up to this point, and what she’s excited to see

Anagenex and Nimbus join forces to develop small molecule treatments using AI

According to the deal terms, Anagenex will generate billions of biochemistry data points for each disease target nominated by Nimbus.

FDA approval expands Welireg to patients with renal cell carcinoma

Welireg was originally approved by the FDA in 2021 for a rare genetic condition. The latest approval allows the drug

Anxiety treated with single dose of psychedelic drug in phase 2b trial

Four weeks after receiving a 100 µg dose of the drug candidate, patients saw a significant reduction in anxiety symptoms

Pharma-grade cannabis contracts secured by Celadon

The UK-company is based on the development, production and sale of the medicines and agreed two commercial contracts on May